MD Anderson Cancer Center: Stereotactic Radiosurgery Recommended for Patients With More Than Three Brain Metastases
October 27, 2020
October 27, 2020
HOUSTON, Texas, Oct. 27 (TNSRes) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Oct. 26:
Researchers from The University of Texas MD Anderson Cancer Center have conducted the first randomized clinical trial comparing stereotactic radiosurgery (SRS) to whole brain radiation therapy (WBRT) in patients with four to 15 brain metastases, providing evidence to support the use of SRS in this patient population.
Results from the . . .
Researchers from The University of Texas MD Anderson Cancer Center have conducted the first randomized clinical trial comparing stereotactic radiosurgery (SRS) to whole brain radiation therapy (WBRT) in patients with four to 15 brain metastases, providing evidence to support the use of SRS in this patient population.
Results from the . . .